The Future of Sterile Fill/Finish

On the penultimate day of the Road to 2021 trip, Cenexi Business Development Director Alexis Paul and Nigel discuss the robust future for sterile fill/finish.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Cenexi

Cenexi is a CDMO specializing in sterile liquid and lyophilized fill-finish, with expertise in both development phase manufacturing as well as commercial oncology products in multiple dosage forms. Its services include formulation, analytical development, process development and optimization, clinical batches, technical transfer and validation, stability testing, regulatory support and product life cycle management. Based in Fontenay, France with four facilities across Europe, Cenexi has the capacity to manage clients projects in their entirety from preformulation and formulation to pilot scale and commercial production for all dosage forms.  

Q: